Even modest post-infection complications can make expanded vaccine coverage cost-effective, modeling suggests

AI Summary

A modeling study led by scientists at the University of British Columbia suggests that even modest complications after infection can make broader vaccine coverage cost-effective. The findings could help public health officials account for longer-term disease impacts when setting vaccination targets.

New modeling led by interdisciplinary scientists at the University of British Columbia (UBC) could help public health officials better factor in the long-term impacts of infectious disease when determining optimal vaccine coverage rates.